| First split-half sample of gender expansive participants | Second split-half sample of gender expansive participants | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
(n = 515) | (n = 516) | ||||||||||||
Omega (95% CI) | M (SD) | Omega (95% CI) | M (SD) | ||||||||||
1 | MDDI DFS | 0.80 (0.76, 0.83) | 8.27 (3.83) | 0.81 (0.76, 0.86) | 8.31 (3.87) |  | − 0.18** | 0.13** | − 0.09* | − 0.08* | − 0.24** | − 0.16** | − 0.18** |
2 | MDDI AI | 0.77 (0.73, 0.80) | 12.92 (3.95) | 0.80 (0.77, 0.82) | 12.71 (4.13) | − 0.11* |  | 0.17** | 0.48** | 0.63** | 0.75** | 0.80** | 0.78** |
3 | MDDI FI | 0.86 (0.78, 0.90) | 6.10 (3.08) | 0.81 (0.76, 0.86) | 6.20 (3.10) | 0.21** | 0.18** | Â | 0.37** | 0.28** | 0.30** | 0.29** | 0.33** |
4 | EDE-Q R | 0.85 (0.83, 0.86) | 1.28 (1.49) | 0.86 (0.83, 0.88) | 1.24 (1.49)) | − 0.07 | 0.41** | 0.36** |  | 0.57** | 0.65** | 0.64** | 0.77** |
5 | EDE-Q EC | 0.85 (0.82, 0.87) | 1.03 (1.26) | 0.86 (0.82, 0.88) | 1.02 (1.28) | − 0.09* | 0.55** | 0.34** | 0.55** |  | 0.73** | 0.75** | 0.81** |
6 | EDE-Q WC | 0.85 (0.83, 0.87) | 2.24 (1.57) | 0.87 (0.85, 0.88) | 2.15 (1.69) | − 0.20** | 0.73** | 0.27** | 0.58** | 0.69** |  | 0.91** | 0.95** |
7 | EDE-Q SC | 0.90 (0.88, 0.91) | 2.64 (1.61) | 0.91 (0.90, 0.92) | 2.55 (1.69) | − 0.08* | 0.79** | 0.32** | 0.56** | 0.67** | 0.86** |  | 0.96** |
8 | EDE-Q G | 0.94 (0.93, 0.95) | 1.95 (1.32) | 0.95 (0.94, 0.96) | 1.89 (1.41) | − 0.12** | 0.76** | 0.36** | 0.74** | 0.78** | 0.92** | 0.94** |  |